2014 Q2 Form 10-Q Financial Statement
#000114420414046802 Filed on August 04, 2014
Income Statement
Concept | 2014 Q2 | 2013 Q2 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $960.0K | $1.070M |
YoY Change | -10.28% | 18.89% |
% of Gross Profit | ||
Research & Development | $1.381M | $1.649M |
YoY Change | -16.26% | 25.42% |
% of Gross Profit | ||
Depreciation & Amortization | $90.00K | $110.0K |
YoY Change | -18.18% | -15.38% |
% of Gross Profit | ||
Operating Expenses | $1.381M | $1.649M |
YoY Change | -16.26% | 25.42% |
Operating Profit | -$2.546M | -$2.723M |
YoY Change | -6.5% | 23.11% |
Interest Expense | -$114.0K | -$2.216K |
YoY Change | 5043.05% | 6.9% |
% of Operating Profit | ||
Other Income/Expense, Net | $459.8K | $658.1K |
YoY Change | -30.14% | -3508.74% |
Pretax Income | -$2.090M | -$2.060M |
YoY Change | 1.46% | -7.62% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$2.086M | -$2.064M |
YoY Change | 1.04% | -7.46% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$69.67M | -$68.67M |
COMMON SHARES | ||
Basic Shares Outstanding | 57.40M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2014 Q2 | 2013 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.630M | $5.830M |
YoY Change | -72.04% | -18.46% |
Cash & Equivalents | $1.626M | $5.828M |
Short-Term Investments | ||
Other Short-Term Assets | $390.0K | $210.0K |
YoY Change | 85.71% | 5.0% |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $2.020M | $6.031M |
YoY Change | -66.5% | -17.84% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $2.190M | $2.513M |
YoY Change | -12.87% | -10.55% |
Goodwill | $1.675M | |
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $10.00K | $27.22K |
YoY Change | -63.27% | -9.26% |
Total Long-Term Assets | $3.870M | $6.094M |
YoY Change | -36.5% | 35.13% |
TOTAL ASSETS | ||
Total Short-Term Assets | $2.020M | $6.031M |
Total Long-Term Assets | $3.870M | $6.094M |
Total Assets | $5.890M | $12.13M |
YoY Change | -51.42% | 2.32% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $1.070M | $1.020M |
YoY Change | 4.9% | 67.21% |
Accrued Expenses | $130.0K | |
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $40.00K | $0.00 |
YoY Change | ||
Total Short-Term Liabilities | $4.078M | $6.091M |
YoY Change | -33.05% | 851.7% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $4.210M | $450.0K |
YoY Change | 835.56% | 0.0% |
Other Long-Term Liabilities | $150.0K | $140.0K |
YoY Change | 7.14% | 7.69% |
Total Long-Term Liabilities | $4.351M | $590.2K |
YoY Change | 637.25% | 1.76% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $4.078M | $6.091M |
Total Long-Term Liabilities | $4.351M | $590.2K |
Total Liabilities | $8.429M | $6.681M |
YoY Change | 26.16% | 447.63% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$56.09M | |
YoY Change | ||
Common Stock | $29.00 | $574.00 |
YoY Change | -94.95% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$2.541M | $5.444M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $5.889M | $12.13M |
YoY Change | -51.43% | 2.32% |
Cashflow Statement
Concept | 2014 Q2 | 2013 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$2.086M | -$2.064M |
YoY Change | 1.04% | -7.46% |
Depreciation, Depletion And Amortization | $90.00K | $110.0K |
YoY Change | -18.18% | -15.38% |
Cash From Operating Activities | -$2.010M | -$2.030M |
YoY Change | -0.99% | 35.33% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $0.00 | $0.00 |
YoY Change | -100.0% | |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | $0.00 |
YoY Change | ||
Cash From Investing Activities | $0.00 | $0.00 |
YoY Change | -100.0% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -170.0K | -10.00K |
YoY Change | 1600.0% | -100.21% |
NET CHANGE | ||
Cash From Operating Activities | -2.010M | -2.030M |
Cash From Investing Activities | 0.000 | 0.000 |
Cash From Financing Activities | -170.0K | -10.00K |
Net Change In Cash | -2.180M | -2.040M |
YoY Change | 6.86% | -160.71% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$2.010M | -$2.030M |
Capital Expenditures | $0.00 | $0.00 |
Free Cash Flow | -$2.010M | -$2.030M |
YoY Change | -0.99% | 36.24% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
1675462 | USD |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2768071 | USD |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
294687 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2360534 | USD |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
11872 | USD |
CY2013Q4 | us-gaap |
Assets
Assets
|
6815939 | USD |
CY2014Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2014Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-56088817 | USD |
CY2014Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2540618 | USD |
CY2014Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5888562 | USD |
CY2014Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
53548170 | USD |
CY2013Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
143234 | USD |
CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
450000 | USD |
CY2014Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
29 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
634658 | shares |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2418384 | USD |
CY2013Q4 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
55000 | USD |
CY2014Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1195418 | USD |
CY2014Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
2840557 | USD |
CY2014Q2 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
431 | USD |
CY2014Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4077736 | USD |
CY2014Q2 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
3796781 | USD |
CY2013Q4 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
0 | USD |
CY2014Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
4351444 | USD |
CY2014Q2 | us-gaap |
Liabilities
Liabilities
|
8429180 | USD |
CY2014Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q2 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
55000 | USD |
CY2013Q4 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
55000 | USD |
CY2014Q2 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
551365 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
826365 | shares |
CY2014Q2 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
2556000 | USD |
CY2013 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.0092 | pure |
us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.0176 | pure | |
CY2013 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
1.09 | pure |
us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
1.08 | pure | |
CY2013 | us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P6Y | |
us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P6Y | ||
CY2014Q1 | us-gaap |
Convertible Debt
ConvertibleDebt
|
4000000 | USD |
CY2014Q1 | clrb |
Convertible Debentures And Warrants To Purchase Common Stock
ConvertibleDebenturesAndWarrantsToPurchaseCommonStock
|
400000 | shares |
CY2014Q1 | clrb |
Payment For Convertible Debentures
PaymentForConvertibleDebentures
|
4000000 | USD |
CY2014Q1 | clrb |
Securities Purchase Agreement Initiation Date
SecuritiesPurchaseAgreementInitiationDate
|
2014-02-05 | |
CY2014Q1 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2016-02-06 | |
CY2014Q1 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
10.00 | |
CY2014Q1 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
400000 | shares |
CY2014Q1 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.08 | pure |
CY2014Q1 | clrb |
Gross Proceeds From Sale Of Securities
GrossProceedsFromSaleOfSecurities
|
2000000 | USD |
CY2014Q1 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.12 | pure |
CY2014Q1 | clrb |
Payment On Default On Borrowings
PaymentOnDefaultOnBorrowings
|
100000 | USD |
CY2014Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
20.00 | |
CY2014Q1 | clrb |
Warrants Expiration Date
WarrantsExpirationDate
|
2019-02-06 | |
CY2014Q1 | clrb |
Default Value Of Borrowings
DefaultValueOfBorrowings
|
150000 | USD |
CY2014Q1 | clrb |
Debt Conversion Converted Instrument Value Warrants Issued
DebtConversionConvertedInstrumentValueWarrantsIssued
|
254000 | USD |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
3746000 | USD | |
CY2014Q2 | us-gaap |
Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
|
128000 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3239450 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3096105 | USD | |
CY2013Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1648838 | USD |
CY2014Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1380798 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2195452 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2046921 | USD | |
CY2013Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1073749 | USD |
CY2014Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
959885 | USD |
us-gaap |
Restructuring Costs
RestructuringCosts
|
0 | USD | |
us-gaap |
Restructuring Costs
RestructuringCosts
|
221815 | USD | |
CY2013Q2 | us-gaap |
Restructuring Costs
RestructuringCosts
|
0 | USD |
CY2014Q2 | us-gaap |
Restructuring Costs
RestructuringCosts
|
204934 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
5434902 | USD | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
5364841 | USD | |
CY2013Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2722587 | USD |
CY2014Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2545617 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5434902 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5364841 | USD | |
CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2722587 | USD |
CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2545617 | USD |
us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
666384 | USD | |
us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
518806 | USD | |
CY2013Q2 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
660341 | USD |
CY2014Q2 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
573751 | USD |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-744957 | USD | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD | |
CY2013Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD |
CY2014Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-4866 | USD | |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-183214 | USD | |
CY2013Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-2216 | USD |
CY2014Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-113970 | USD |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-2.03 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.75 | ||
CY2013Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.72 | |
CY2014Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.73 | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2717966 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2869739 | shares | |
CY2013Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2869739 | shares |
CY2014Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2869739 | shares |
CY2014Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
1964085 | shares |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
803791 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
536216 | USD | |
CY2013Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
377893 | USD |
CY2014Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
273690 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.09 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.08 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0092 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0176 | pure | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
14.80 | ||
CY2014Q2 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Unvested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsUnvestedOutstandingNumber
|
354911 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
264752 | shares |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
6.20 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
20000 | shares | |
clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
|
20521 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
14474 | shares | |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
619663 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
264752 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
18.20 | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
7.40 | ||
clrb |
Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
|
23.17 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
15.00 | ||
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
17.80 | |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
29.00 | |
CY2014Q2 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedExercisableWeightedAverageExercisePrice
|
9.20 | |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
29.00 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P4Y14D | ||
clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
|
P9Y3M4D | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y14D | ||
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
CY2014Q2 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingAggregateIntrinsicValue
|
0 | USD |
CY2014Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
81805 | shares | |
clrb |
Employee Service Share Based Compensation Nonvested Total Compensation In Current Year
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInCurrentYear
|
1096000 | USD | |
clrb |
Employee Service Share Based Compensation Nonvested Total Compensation In Year Two
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearTwo
|
570000 | USD | |
clrb |
Employee Service Share Based Compensation Nonvested Total Compensation In Year Three
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearThree
|
203000 | USD | |
CY2014Q2 | clrb |
Weighted Average Grant Date Fair Value Of Vested Options Outstanding
WeightedAverageGrantDateFairValueOfVestedOptionsOutstanding
|
16.66 | |
CY2014Q2 | clrb |
Weighted Average Grant Date Fair Value Of Unvested Options Outstanding
WeightedAverageGrantDateFairValueOfUnvestedOptionsOutstanding
|
5.98 | |
CY2014Q2 | clrb |
Share Based Compensation Arrangement By Sharebased Payment Award Options Unvested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedAndExpectedToVestOutstandingNumber
|
273106 | shares |
clrb |
Estimated Stock Based Compensation Expense Up On Vesting Of Options
EstimatedStockBasedCompensationExpenseUpOnVestingOfOptions
|
418000 | USD | |
CY2014Q1 | clrb |
Antidilution Option Reduced By Expiration Of Warrants
AntidilutionOptionReducedByExpirationOfWarrants
|
14474 | shares |
CY2014Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
10.00 | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
219968 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
188369 | USD | |
clrb |
Noncash Interest Expense Related To Discount On Convertible Debt
NoncashInterestExpenseRelatedToDiscountOnConvertibleDebt
|
0 | USD | |
clrb |
Noncash Interest Expense Related To Discount On Convertible Debt
NoncashInterestExpenseRelatedToDiscountOnConvertibleDebt
|
50805 | USD | |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-2268 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-3922597 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-4602340 | USD | |
us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-121768 | USD | |
us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
28791 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-15191 | USD | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
4000000 | USD | |
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
1178 | USD | |
us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
1263 | USD | |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
70539 | USD | |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-172407 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
5044514 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
3825172 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1150708 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-792359 | USD | |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4677545 | USD |
clrb |
Debt Conversion Converted Instrument Value Warrants Issued
DebtConversionConvertedInstrumentValueWarrantsIssued
|
254024 | USD | |
clrb |
Payment Of Lump Sum Amount Related To Employment Agreement
PaymentOfLumpSumAmountRelatedToEmploymentAgreement
|
160000 | USD | |
clrb |
Payment Towards Clinical Trial Agreements
PaymentTowardsClinicalTrialAgreements
|
264000 | USD | |
CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5828253 | USD |
clrb |
Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
|
5720000 | USD | |
clrb |
Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
|
0 | USD | |
clrb |
Debt Conversion Converted Instrument Value Warrants Issued
DebtConversionConvertedInstrumentValueWarrantsIssued
|
0 | USD | |
CY2014Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
41330 | USD |
CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
0 | USD |
us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-4391 | USD | |
us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-2622 | USD | |
clrb |
Reverse Stock Split Fractional Shares
ReverseStockSplitFractionalShares
|
0 | USD | |
clrb |
Reverse Stock Split Fractional Shares
ReverseStockSplitFractionalShares
|
1158 | USD | |
us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
At the annual meeting of stockholders held on May 22, 2014, the Company’s stockholders approved an amendment to the certificate of incorporation to effect a reverse split of the Company’s common stock at a ratio between 1:10 to 1:20 in order to satisfy requirements for the listing of the Company’s common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue would be reduced from 150,000,000 to the greater of (A) 20,000,000 and (B) the number of shares equal to three (3) times the sum of the number of all shares of common stock outstanding and the number of shares of common stock issuable upon exercise or conversion of all outstanding options, warrants and convertible debt. | ||
clrb |
Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
|
1-for-20 | ||
CY2014Q2 | clrb |
Common Stock Shares Previously Authorized
CommonStockSharesPreviouslyAuthorized
|
150000000 | shares |
CY2014Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
275000 | shares |
clrb |
Amount Invoiced Under Clinical Trial Agreements
AmountInvoicedUnderClinicalTrialAgreements
|
334000 | USD | |
us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
62500 | USD | |
CY2014Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
254000 | USD |
CY2013Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
96278 | shares |
CY2014Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1869000 | USD |
CY2013Q4 | clrb |
Antidilution Option Reduced Rate
AntidilutionOptionReducedRate
|
19 | shares |